Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

  • 1 of 1

Pfizer has lost its patent infringement case against generic drug manufacturers Actavis and Mylan over the use of pregabalin, which Pfizer markets as Lyrica. In the image, package of Pfizer's Lyrica

Pfizer intends to appeal the High Court ruling on Lyrica’s second medical use patent

Source  Barry Mason / Alamy Stock Photo